blank
blank

Your Tag: Portugal

Cover for the State-of-the-Art RD Country Reports 2025

State of the Art 2025 RD Report: Portugal

This 2025 country report outlines the policy, research, care and support landscape for rare diseases in Portugal.
“The National Mirror Group was the first time patients had been treated as equal partners in this kind of forum, and it immediately changed the conversation”

“The National Mirror Group was the first time patients had been treated as equal partners in this kind of forum, and it immediately changed the conversation”

ERDERA meets Sandra Alves, a senior human-genetics researcher at the National Institute of Health Dr Ricardo Jorge (INSA), and Coordinator of the Portuguese National Mirror Group (NMG).

ERDERA launches Clinical Trial Call 2026 to advance early-phase clinical trials for rare diseases

ERDERA has opened its Clinical Trial Call 2026 to support multinational early-phase clinical trials in rare diseases. The call will fund sponsor-led, GCP-compliant studies designed to generate robust clinical evidence, strengthen regulatory readiness and make rare disease trials more feasible across countries.

ERDERA's

search form